Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds

Detalhes bibliográficos
Autor(a) principal: Barros,Andrea Barbieri
Data de Publicação: 2014
Outros Autores: Rodrigues,Alex Miranda, Batista,Mariane Pereira, Munhoz Junior,Sidney, Hueb,Marcia, Fontes,Cor Jesus
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Memórias do Instituto Oswaldo Cruz
Texto Completo: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762014000400499
Resumo: Antimony compounds are the cornerstone treatments for tegumentary leishmaniasis. The reactivation of herpes virus is a side effect described in few reports. We conducted an observational study to describe the incidence of herpes zoster reactivation during treatment with antimony compounds. The global incidence of herpes zoster is approximately 2.5 cases per 1,000 persons per month (or 30 cases per 1,000 persons per year). The estimated incidence of herpes zoster in patients undergoing antimony therapy is higher than previously reported.
id FIOCRUZ-4_bc5376d835e0400e699d4c077f7c16e5
oai_identifier_str oai:scielo:S0074-02762014000400499
network_acronym_str FIOCRUZ-4
network_name_str Memórias do Instituto Oswaldo Cruz
spelling Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compoundsleishmaniasisherpes zosterantimony therapyAntimony compounds are the cornerstone treatments for tegumentary leishmaniasis. The reactivation of herpes virus is a side effect described in few reports. We conducted an observational study to describe the incidence of herpes zoster reactivation during treatment with antimony compounds. The global incidence of herpes zoster is approximately 2.5 cases per 1,000 persons per month (or 30 cases per 1,000 persons per year). The estimated incidence of herpes zoster in patients undergoing antimony therapy is higher than previously reported.Instituto Oswaldo Cruz, Ministério da Saúde2014-07-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762014000400499Memórias do Instituto Oswaldo Cruz v.109 n.4 2014reponame:Memórias do Instituto Oswaldo Cruzinstname:Fundação Oswaldo Cruzinstacron:FIOCRUZ10.1590/0074-0276130563info:eu-repo/semantics/openAccessBarros,Andrea BarbieriRodrigues,Alex MirandaBatista,Mariane PereiraMunhoz Junior,SidneyHueb,MarciaFontes,Cor Jesuseng2020-04-25T17:51:51Zhttp://www.scielo.br/oai/scielo-oai.php0074-02761678-8060opendoar:null2020-04-26 02:20:04.235Memórias do Instituto Oswaldo Cruz - Fundação Oswaldo Cruztrue
dc.title.none.fl_str_mv Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds
title Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds
spellingShingle Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds
Barros,Andrea Barbieri
leishmaniasis
herpes zoster
antimony therapy
title_short Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds
title_full Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds
title_fullStr Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds
title_full_unstemmed Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds
title_sort Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds
author Barros,Andrea Barbieri
author_facet Barros,Andrea Barbieri
Rodrigues,Alex Miranda
Batista,Mariane Pereira
Munhoz Junior,Sidney
Hueb,Marcia
Fontes,Cor Jesus
author_role author
author2 Rodrigues,Alex Miranda
Batista,Mariane Pereira
Munhoz Junior,Sidney
Hueb,Marcia
Fontes,Cor Jesus
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Barros,Andrea Barbieri
Rodrigues,Alex Miranda
Batista,Mariane Pereira
Munhoz Junior,Sidney
Hueb,Marcia
Fontes,Cor Jesus
dc.subject.por.fl_str_mv leishmaniasis
herpes zoster
antimony therapy
topic leishmaniasis
herpes zoster
antimony therapy
dc.description.none.fl_txt_mv Antimony compounds are the cornerstone treatments for tegumentary leishmaniasis. The reactivation of herpes virus is a side effect described in few reports. We conducted an observational study to describe the incidence of herpes zoster reactivation during treatment with antimony compounds. The global incidence of herpes zoster is approximately 2.5 cases per 1,000 persons per month (or 30 cases per 1,000 persons per year). The estimated incidence of herpes zoster in patients undergoing antimony therapy is higher than previously reported.
description Antimony compounds are the cornerstone treatments for tegumentary leishmaniasis. The reactivation of herpes virus is a side effect described in few reports. We conducted an observational study to describe the incidence of herpes zoster reactivation during treatment with antimony compounds. The global incidence of herpes zoster is approximately 2.5 cases per 1,000 persons per month (or 30 cases per 1,000 persons per year). The estimated incidence of herpes zoster in patients undergoing antimony therapy is higher than previously reported.
publishDate 2014
dc.date.none.fl_str_mv 2014-07-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762014000400499
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762014000400499
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/0074-0276130563
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Instituto Oswaldo Cruz, Ministério da Saúde
publisher.none.fl_str_mv Instituto Oswaldo Cruz, Ministério da Saúde
dc.source.none.fl_str_mv Memórias do Instituto Oswaldo Cruz v.109 n.4 2014
reponame:Memórias do Instituto Oswaldo Cruz
instname:Fundação Oswaldo Cruz
instacron:FIOCRUZ
reponame_str Memórias do Instituto Oswaldo Cruz
collection Memórias do Instituto Oswaldo Cruz
instname_str Fundação Oswaldo Cruz
instacron_str FIOCRUZ
institution FIOCRUZ
repository.name.fl_str_mv Memórias do Instituto Oswaldo Cruz - Fundação Oswaldo Cruz
repository.mail.fl_str_mv
_version_ 1669937717060829184

Registros relacionados